Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418626081> ?p ?o ?g. }
- W2418626081 abstract "Routine phenotypic methods employing clavulanate and third generation cephalosporins to detect ESBL are not promising for isolates that co-produce an inhibitor-resistant beta lactamase like AmpC.Enhancing phenotypic detection of ESBL in AmpC co-producers by using cefepime and tazobactam.A total of 245 isolates of Escherichia coli (123), Klebsiella spp. (87), Proteus spp.(20), Enterobacter spp. (9) and Citrobacter spp.(6) obtained over a period of 2 years from January 2013 to December 2014 from urine samples of hospitalized patients were studied. The isolates were simultaneously screened for ESBL and AmpC production. AmpC production was confirmed by modified three -dimensional test (MTDT). ESBL production was confirmed by original double disc synergy test, phenotypic disc confirmatory test (PDCT) and modified double disc synergy test (MDDST) and the results compared.AmpC production was confirmed in 113 (46.1%) isolates by modified three dimensional test out of 143 screened positive for AmpC. Of the 192 isolates screened positive for ESBL, ESBL production was confirmed in 162 (66.1%). DDST detected ESBLs in only134 (54.7%) while additional 28 (11.4%) ESBL positive isolates were detected by MDDST. PDCT detected total 145(59.2%) ESBL positive isolates, with cefotaxime and cefotaxime + clavulanate detecting 139 (56.7%) and ceftazidime and ceftazidime + clavulanate detecting additional 6 isolates. All the 28 (11.4%) isolates which were additionally detected ESBL producers by MDDST showed positive three dimensional test i.e. AmpC co producers. DDST detected ESBL in none of AmpC positive isolates while PDCT detected ESBL in 11 isolates showing AmpC co-production. In MDDST cefepime was the best cephalosporin in detecting ESBL in presence of AmpC production. It showed synergism with amoxicillin-clavulanate in 11(39.3%) isolates and in 24(85.7%) isolates with piperacillin-tazobactam. Third generation cephalosporins -cefotaxime, ceftazidime and cefpodoxime were not able to detect ESBL in AmpC-co producers.Modification of double disc synergy tests that combine piperacillin-tazobactum with cefepime enhances the possibility of ESBL detection." @default.
- W2418626081 created "2016-06-24" @default.
- W2418626081 creator A5006376604 @default.
- W2418626081 creator A5053573043 @default.
- W2418626081 creator A5059244837 @default.
- W2418626081 creator A5063497326 @default.
- W2418626081 creator A5089284052 @default.
- W2418626081 date "2016-01-01" @default.
- W2418626081 modified "2023-10-01" @default.
- W2418626081 title "Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam" @default.
- W2418626081 cites W1526420233 @default.
- W2418626081 cites W1582600392 @default.
- W2418626081 cites W1836907173 @default.
- W2418626081 cites W1921319550 @default.
- W2418626081 cites W1985467310 @default.
- W2418626081 cites W2015851594 @default.
- W2418626081 cites W2026030603 @default.
- W2418626081 cites W2062389905 @default.
- W2418626081 cites W2067949559 @default.
- W2418626081 cites W2083696450 @default.
- W2418626081 cites W2103186991 @default.
- W2418626081 cites W2130748549 @default.
- W2418626081 cites W2152097275 @default.
- W2418626081 cites W2163870515 @default.
- W2418626081 doi "https://doi.org/10.7860/jcdr/2016/15264.7041" @default.
- W2418626081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4740591" @default.
- W2418626081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26894064" @default.
- W2418626081 hasPublicationYear "2016" @default.
- W2418626081 type Work @default.
- W2418626081 sameAs 2418626081 @default.
- W2418626081 citedByCount "9" @default.
- W2418626081 countsByYear W24186260812017 @default.
- W2418626081 countsByYear W24186260812019 @default.
- W2418626081 countsByYear W24186260812021 @default.
- W2418626081 countsByYear W24186260812022 @default.
- W2418626081 countsByYear W24186260812023 @default.
- W2418626081 crossrefType "journal-article" @default.
- W2418626081 hasAuthorship W2418626081A5006376604 @default.
- W2418626081 hasAuthorship W2418626081A5053573043 @default.
- W2418626081 hasAuthorship W2418626081A5059244837 @default.
- W2418626081 hasAuthorship W2418626081A5063497326 @default.
- W2418626081 hasAuthorship W2418626081A5089284052 @default.
- W2418626081 hasBestOaLocation W24186260811 @default.
- W2418626081 hasConcept C104317684 @default.
- W2418626081 hasConcept C2776968632 @default.
- W2418626081 hasConcept C2777050379 @default.
- W2418626081 hasConcept C2777058267 @default.
- W2418626081 hasConcept C2777637488 @default.
- W2418626081 hasConcept C2778266534 @default.
- W2418626081 hasConcept C2778719061 @default.
- W2418626081 hasConcept C2778983983 @default.
- W2418626081 hasConcept C2779631663 @default.
- W2418626081 hasConcept C2781288988 @default.
- W2418626081 hasConcept C501593827 @default.
- W2418626081 hasConcept C523546767 @default.
- W2418626081 hasConcept C54355233 @default.
- W2418626081 hasConcept C547475151 @default.
- W2418626081 hasConcept C55493867 @default.
- W2418626081 hasConcept C64778159 @default.
- W2418626081 hasConcept C86803240 @default.
- W2418626081 hasConcept C89423630 @default.
- W2418626081 hasConcept C94665300 @default.
- W2418626081 hasConceptScore W2418626081C104317684 @default.
- W2418626081 hasConceptScore W2418626081C2776968632 @default.
- W2418626081 hasConceptScore W2418626081C2777050379 @default.
- W2418626081 hasConceptScore W2418626081C2777058267 @default.
- W2418626081 hasConceptScore W2418626081C2777637488 @default.
- W2418626081 hasConceptScore W2418626081C2778266534 @default.
- W2418626081 hasConceptScore W2418626081C2778719061 @default.
- W2418626081 hasConceptScore W2418626081C2778983983 @default.
- W2418626081 hasConceptScore W2418626081C2779631663 @default.
- W2418626081 hasConceptScore W2418626081C2781288988 @default.
- W2418626081 hasConceptScore W2418626081C501593827 @default.
- W2418626081 hasConceptScore W2418626081C523546767 @default.
- W2418626081 hasConceptScore W2418626081C54355233 @default.
- W2418626081 hasConceptScore W2418626081C547475151 @default.
- W2418626081 hasConceptScore W2418626081C55493867 @default.
- W2418626081 hasConceptScore W2418626081C64778159 @default.
- W2418626081 hasConceptScore W2418626081C86803240 @default.
- W2418626081 hasConceptScore W2418626081C89423630 @default.
- W2418626081 hasConceptScore W2418626081C94665300 @default.
- W2418626081 hasLocation W24186260811 @default.
- W2418626081 hasLocation W24186260812 @default.
- W2418626081 hasLocation W24186260813 @default.
- W2418626081 hasLocation W24186260814 @default.
- W2418626081 hasOpenAccess W2418626081 @default.
- W2418626081 hasPrimaryLocation W24186260811 @default.
- W2418626081 hasRelatedWork W1971812639 @default.
- W2418626081 hasRelatedWork W2036297853 @default.
- W2418626081 hasRelatedWork W2041721984 @default.
- W2418626081 hasRelatedWork W2097999145 @default.
- W2418626081 hasRelatedWork W2107627260 @default.
- W2418626081 hasRelatedWork W2111619318 @default.
- W2418626081 hasRelatedWork W2120588426 @default.
- W2418626081 hasRelatedWork W2148493445 @default.
- W2418626081 hasRelatedWork W2154981049 @default.
- W2418626081 hasRelatedWork W2726304507 @default.
- W2418626081 isParatext "false" @default.
- W2418626081 isRetracted "false" @default.
- W2418626081 magId "2418626081" @default.